1. Introduction {#Section1}
===============

Tuberculosis (TB) is still a public health challenge worldwide [@B1],[@B2].As reported by the latest 2012 global tuberculosis report, in 2011, it is estimated that there were 8.7 million new cases of TB and 1.4 million people died from TB, including almost 1 million deaths among HIV-negative individuals and 430, 000 among people who were HIV-positive [@B3]. Recent studies suggest that host genetic factors play critical roles in the pathogenesis and outcome of TB, especially genetic polymorphisms in the immune response to *Mycobacterium tuberculosis* (*M. tuberculosis*) may explain individual differences in both susceptibility to disease and the course of infection [@B4]-[@B6]. Up to now, quite a lot studies have investigated the association between TB susceptibility and genetic variants among which the CD 14 gene has been highlighted.

The CD14 gene is localized on chromosome 5q31.1 and CD14 is a membrane recognition factor involved in the binding of bacterial components or inhaled endotoxin, which can induce significant lung inflammation and activate immune pathways [@B7]. CD14 contributes to receptor-mediated ingestion of non-opsonised *M. tuberculosis* by mononuclear cells such as macrophages through recognizing components of the cell wall [@B8]. As previously shown in genetic studies, a polymorphism in the CD14 proximal promoter, -159C/T (rs2569190), might interact with environmental factors in the development of TB. Several studies have investigated whether the -159C/T polymorphism in the CD14 gene is associated with TB risk, and, the results have been inconsistent and inconclusive. Since pooled estimates using meta-analysis have proven to be useful in determining the overall risk of certain polymorphisms [@B9], the present meta-analysis aimed to clarify the association between the -159C/T polymorphism in the CD14 gene and TB risk.

2. Method {#Section2}
=========

2.1 Literature search {#Section2.1}
---------------------

A systematic literature search in Pubmed and Embase databases was performed by two independent reviewers to identify studies examining the possible association between -159C/T polymorphism in the CD14 gene and TB risk on Jan 15, 2013. Search terms were as follows: "TB *or* tuberculosis" in combination with "CD14" in combination with "polymorphism *or*variant *or* mutation". The reference lists of identified studies and review articles were manually searched to find additional relevant publications.

2.2 Study selection {#Section2.2}
-------------------

Studies were included in the meta-analysis if they satisfied the following inclusion criteria: (1) they evaluated the potential association between the -159C/T polymorphism in the CD14 gene and TB risk, (2) they were case-control studies, (3) genotype distributions were available for cases and controls in order to estimate an odds ratio (OR) with 95% confidence interval (CI); and (4) the distribution of genotypes in the control group was consistent with Hardy-Weinberg equilibrium (HWE). Accordingly, abstracts, reviews, and studies in which genotype frequencies were not reported were excluded. When publications involved the same or overlapping data sets, only the study with the largest number of participants was included.

2.3 Data extraction {#Section2.3}
-------------------

Two reviewers independently extracted data from the final set of included studies (T Wang and Y Shen), and the differences between them were solved by consensus. The following items were extracted from each study if available: first author, year of publication, country of origin, ethnicity, sample size, TB definition, genotyping method, and genotype number frequencies in TB cases and controls.

2.4 Statistical analysis {#Section2.4}
------------------------

The strength of the association between the -159C/T polymorphism in the CD14 gene and risk of TB was assessed using OR and 95% CI. The significance of the pooled OR was determined using the Z-test and *P*\< 0.05 was considered statistically significant. Firstly, we evaluated with the dominant model (TT+TC vs. CC) and recessive model (TT vs. TC+CC) and then evaluated variant genotype TT and compared with the wild-type CC homozygote (TT vs. CC). In addition, we also estimated the risks of TC vs. CC and T vs. C.

Heterogeneity was evaluated using a χ^2^-based Q statistic and I^2^ statistic, with *P*\< 0.10 considered statistically significant. When *P ≥* 0.10, the pooled OR of each study was calculated using a fixed-effects model; otherwise, a random-effects model was used. Publication bias was assessed using Begg\'s funnel plots and Egger\'s test [@B10],[@B11]. Sensitivity analysis was performed by sequentially excluding individual studies and recalculating the results. HWE was tested using a web-based program (<http://ihg2.helmholtz-muenchen.de/cgi-bin/hw/hwa1.pl>). All statistical tests were performed using Revman 5.1 and STATA 12.0 software.

3. Results {#Section3}
==========

3.1 Characteristics of included studies {#Section3.1}
---------------------------------------

After independent review, a total of seven studies evaluating the association between the -159C/T polymorphism in the CD14 gene and TB risk were included in the meta-analysis, involving 3253 subjects (1,574 TB cases and 1,679 controls) [@B12]-[@B18]. There were four case-controls of Asians [@B12],[@B14],[@B17],[@B18], two of Latinos [@B15],[@B16], and one of Caucasian [@B13]. Of the seven included studies, genotype frequencies for control group were all consistent with HWE. The characteristics of each case-control study are summarized in Table [1](#T1){ref-type="table"}, and, genotype and allele distributions for each case-control studies are listed in Table [2](#T2){ref-type="table"}.

3.2 Quantitative data synthesis {#Section3.2}
-------------------------------

First, we analyzed the heterogeneity of TT+TC vs. CC in order to choose the best calculation model. For included seven studies, the value of χ^2^ was 20.07 with *P*=0.003 in a random-effects model, and I-square value, another index of heterogeneity, was 70%, both suggesting a significant of heterogeneity. Thus, we chose the random-effects model to synthesize the data. Overall, the pooled OR was 1.31 (95% CI: 0.93-1.84) and the test for overall effect Z value was 1.52 (*P*=0.13) (Fig.[1](#F1){ref-type="fig"}). These results suggested that the TT homozygote and TC heterozygote carriers have an increased risk of TB compared with those individuals with the CC homozygote; however, there was no statistical significance. As suggested by Thakkinstian et al [@B19], the recessive model is the best genetic model for evaluating the association between the -159C/T polymorphism in the CD14 gene and TB risk. We noticed that the TT homozygote carriers have an increased risk of TB compared with those individuals with the TC and CC homozygote with an OR of 1.66 (95% CI: 1.23-2.25) (*P*\<0.05, Fig. [2](#F2){ref-type="fig"}), indicating the -159C/T polymorphism is a risk factor for TB. Summary of the results of other genetic comparisons are listed in Table [3](#T3){ref-type="table"}.

In the subgroup analysis by ethnicity, no associations were found in Latinos (OR= 1.79, 95% CI: 0.39-8.18, *P*=0.46) in recessive model (TT vs. TC+CC). While we found an obvious association between -159C/T polymorphism in the CD14 gene and the TB susceptibility in dominant model (TT+TC vs. CC), recessive model (TT vs. TC+CC), and allelic genetic model (T vs. C), as shown in Table [3](#T3){ref-type="table"}, suggesting -159C/T polymorphism is a genetic risk factor for TB in Asians.

3.3 Sensitivity analysis and Publication bias {#Section3.3}
---------------------------------------------

To estimate the stability of our findings, sensitivity analysis was performed by sequentially excluding each study. Statistically similar results were obtained after sequentially excluding each case-control study, showing the stability of the results (Fig.[3](#F3){ref-type="fig"}). Begg\'s funnel plot and Egger\'s test were used to assess publication bias. The shape of the funnel plots seemed symmetrical in the TT vs. TC+CC comparison genetic model, suggesting the absence of publication bias (Fig. [4](#F4){ref-type="fig"}). Then, the Egger\'s test was performed to provide statistical evidence of funnel plots symmetry. The results indicated a lack of publication bias of the current meta-analysis (*P*=0.315).

4. Discussion {#Section4}
=============

TB remains a leading cause of mortality worldwide, while the pathogenesis of TB has not been well understood [@B1],[@B2]. Gene variants may alter protein production, function and individual\'s susceptibility to disease, thus, may play a role in pathogenesis of TB [@B6]. CD14 is one of the extracellular adaptor proteins required for recognition of *M. tuberculosis*, and it is important for eliciting lung inflammatory response during *M. tuberculosis* infection which during progressive disease can result enhanced mortality [@B20]. The -159C/T polymorphism in the gene CD14 might interact with environmental factors in the development of TB. Recently, it has been demonstrated that individuals with CD14 -159 TT genotype had increased serum CD14 levels [@B12]. It is proposed that the up-regulation of CD14 expression can ease immune interactions with mannosylated lipoarabinomannan, which subsequently enhances the production of transforming growth factor -β and suppresses the immune response, thus, make subjects at a high risk of TB [@B21]. The correlation of CD 14 polymorphism and TB risk has been studied, but the results remain controversial. Therefore, we performed this meta-analysis to clarify the relationship between this polymorphism and susceptibility to TB. To our best knowledge, it is the most comprehensive meta-analysis regarding the -159C/T polymorphism and TB risk.

A total of seven case-control studies in Asians, Latinos, and Caucasians were included in the meta-analysis. The strength of the present analysis was based on the accumulation of published data giving information to detect more precise conclusion. In this study, the effect of dominant/recessive models and the effect of allele frequency were all estimated to investigate the precise role of -159C/T polymorphism in TB. Moreover, the consistency of genetic effects across populations from different ethnicities was investigated. For the present meta-analysis, research findings do support a role for the CD14-159C/T polymorphism in the development of TB in the total combined analysis (TT vs. TC+CC), the TT homozygote carriers have an increased risk of TB compared with those individuals with the TC and CC homozygote. Rosas-Taraco et al also found that CD14-159TT appear to be a risk factor for the development of pulmonary TB in Latinos [@B16]. Sub-group analysis suggested that the CD14-159C/T polymorphism is an increased risk factor for TB in Asians, while not in Latinos. Considering the ethnic difference, there may be differences in the genes involved in different populations, thus, to take of a further investigation of population differences will be particularly informative, and susceptibility genes identified in TB patients with different ethnicities may provide an opportunity to explore new mechanisms of disease that are specific in different population.

The findings in this meta-analysis should be interpreted with caution because of several limitations. First, a relatively small number of studies and subjects were included, which may reduce the statistical power for identifying possible association between the -159C/T polymorphism and TB risk. Second, the seven included studies were performed majorly in Asian or Latino populations, only one in Caucasian [@B13], thus more studies are needed in other ethnic population such as Caucasians because of possible ethnic differences of the -159C/T polymorphism. Third, although we didn\'t set any restrictions during our literature searching, we included only English-language publications in the present meta-analysis. It is possible that including relevant published studies in other languages or unpublished studies which had null outcomes may alter our results.

5. Conclusions {#Section5}
==============

To our knowledge, this is the first meta-analysis to assess the relationship between the -159C/T polymorphism in CD14 gene and TB risk. Our results suggest that the -159C/T polymorphism was significantly associated with TB risk, especially in Asian population. In the future, large well-designed and multi-center epidemiological studies in different ethnic population should be performed to assess these associations.
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###### 

Characteristics of included studies.

  Author               Year   Country    Ethnicity   Tuberculosis   Mean age   Control   Mean age   Genotyping method   TB definition   HWE
  -------------------- ------ ---------- ----------- -------------- ---------- --------- ---------- ------------------- --------------- -----
  Alavi-Naini et al    2012   Iran       Asian       120            51.5       131       48.1       PCR                 B               Y
  Ayaslioglu et al     2012   Turkey     Caucasian   88             49.93      116       32.96      PCR                 B, HP, CD       Y
  Kang et al           2009   Korea      Asian       274            38.0       422       24.0       PCR                 B, HP, CD       Y
  Pacheco et al        2004   Colombia   Latino      267            NA         112       NA         PCR-RFLP            B, HP, CD       Y
  Rosas-Taraco et al   2007   México     Latino      104            39.5       114       26.3       PCR-RFLP            B, CD           Y
  Xue et al            2012   China      Asian       311            38.0       380       37.7       PCR                 B, CD           Y
  Zhao et al           2012   China      Asian       410            38.5       404       36.7       PCR                 B, CD           Y

NA: Not available; PCR: Polymerase chain reaction; RFLP: Restriction fragment length polymorphism; B: Bacteriology; HP: Histopathology; CD: Clinical diagnosis; HWE: Hardy-Weinberg equilibrium; Y: Yes.

###### 

Distribution of CD14 genotype and allele among TB patients and controls

  Author               TB   Control   TB    Control                                 
  -------------------- ---- --------- ----- --------- ----- ----- ----- ----- ----- -----
  Alavi-Naini et al    18   66        36    38        71    22    102   138   147   115
  Ayaslioglu et al     16   43        29    15        59    42    75    101   89    143
  Kang et al           39   118       117   72        215   135   196   352   359   485
  Pacheco et al        92   119       56    31        54    27    303   231   116   108
  Rosas-Taraco et al   16   51        37    37        63    14    83    125   137   91
  Xue et al            47   121       143   91        175   114   215   407   357   413
  Zhao et al           75   149       186   76        208   120   299   521   360   448

TB: Tuberculosis

###### 

Summary of different comparative results.

                              TT+TC vs. CC           TT vs. TC+CC   TT vs.CC               TC vs. CC       T vs.C                                                                                   
  --------------------------- ---------------------- -------------- ---------------------- --------------- ---------------------- --------------- ------------------ ------- ---------------------- ---------------
                              OR (95%CI)             *P\**          OR (95%CI)             *P\**           OR (95%CI)             *P\**           OR (95%CI)         *P\**   OR (95%CI)             *P\**
  Total                       1.31 (0.93-1.84)       0.13           **1.66 (1.23-2.25)**   **0.0009**      **1.76 (1.10-2.81)**   **0.02**        1.07 (0.79-1.44)   0.68    **1.36 (1.08-1.70)**   **0.008**
  **Subgroup by Ethnicity**                                                                                                                                                                         
  Latino                      1.36 (0.38-4.81)       0.63           1.79 (0.39-8.18)       0.46            2.02 (0.24-16.96)      0.52            1.14 (0.46-2.83)   0.77    1.35 (0.50-3.67)       0.55
  Asian                       **1.39 (1.13-1.71)**   **0.002**      **1.87 (1.58-2.21)**   **\<0.00001**   **1.93 (1.53-2.44)**   **\<0.00001**   1.12 (0.76-1.65)   0.56    **1.48 (1.31-1.66)**   **\<0.00001**

The bold values mean that their association is significant, \* *P* value for Z test.
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